Justin Grodin, M.D., M.P.H. Medical Director, Internal Medicine Clinical Trials Unit Associate Professor School Medical School Department Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Download Curriculum Vitae Justin Grodin, M.D., M.P.H., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Cardiology. He also serves as the Medical Director of the Internal Medicine Clinical Trials Unit. I take a lot of pride in helping my patients understand their diagnosis, and in reassuring them that they’re getting the most thorough evaluation and best, personalized treatment. Originally from El Paso, Texas, Dr. Grodin holds a bachelor's degree in chemistry from the University of Texas at Austin. He earned his medical degree at UT Southwestern, where he also completed internal medicine residency training. He completed advanced training through two fellowships at the Cleveland Clinic, one in cardiovascular disease and one in advanced heart failure and transplant cardiology. Dr. Grodin also holds a master’s degree in public health from the Harvard T.H. Chan School of Public Health in Boston, Massachusetts. Certified by the American Board of Internal Medicine in cardiovascular disease, advanced heart failure, and transplant cardiology, and by the National Board of Echocardiography, Dr. Grodin joined the UT Southwestern faculty in 2016. His clinical focus is in cardiac amyloidosis, hypertrophic cardiomyopathy, advanced heart failure, cardiac transplantation, left-ventricular assist devices, and cardiac critical care. In addition, Dr. Grodin splits his professional time as a clinical epidemiologist focusing on heart failure outcomes research. One of the primary objectives of his research includes identifying subclinical markers of risk across a spectrum of heart failure severity and in transthyretin cardiac amyloidosis patients. He leads multicenter epidemiological research studies including clinical trials for transthyretin cardiac amyloidosis and serves on international steering committees for cardiac amyloidosis research consortia. He also serves as site-PI for international registry studies and clinical trials testing novel treatments for transthyretin cardiac amyloidosis. Dr. Grodin's other research interests include heart failure, the treatment of acute heart failure, cardiorenal syndrome, and metabolic and hemodynamic biomarkers of heart failure. His research has been continuously funded by the National Institutes of Health, foundation grants, and industry since 2018. Dr. Grodin has over 100 peer-reviewed publications in scientific journals. He serves as an Associate Editor for Circulation, a Section Editor for Current Heart Failure Reports, and on the Editorial Board for Amyloid. He is also an ad-hoc reviewer for dozens of journals. Dr. Grodin is a member of the American College of Cardiology, the Heart Failure Society of America, and the International Society for Amyloidosis. Education Medical School UT Southwestern Medical School (2009) Residency UT Southwestern Medical Center (2012), Internal Medicine Fellowship Cleveland Clinic Foundation (2015), Cardiovascular Disease Other Post Graduate Training Harvard School of Public Health (2015) Graduate School Harvard School of Public Health (2015) Fellowship Cleveland Clinic Foundation (2016), Advanced Heart Failure & Transplant Cardiology Research Interest Acute Heart Failure Advanced Heart Failure Cardiac Amyloidosis Cardiac Transplantation and Ventricular Assist Devices Cardiorenal Physiology Heart Failure Epidemiology Publications Featured Publications Trends and causes of hospitalizations in patients with amyloidosis. Patil N, Arora S, Qamar A, Strassle PD, Alexander KM, Fatima A, Maurer MS, Grodin JL, Pandey A, Amyloid 2019 Jun 1-2 Association of Galectin-3 with Diabetes Mellitus in the Dallas Heart Study. Vora A, de Lemos JA, Ayers C, Grodin JL, Lingvay I, J. Clin. Endocrinol. Metab. 2019 Jun Implications of Perceived Dyspnea and Global Well-Being Measured by Visual Assessment Scales During Treatment for Acute Decompensated Heart Failure. Hendren NS, Drazner MH, Pandey A, Tang WHW, Grodin JL, Am. J. Cardiol. 2019 May Identifying a low-flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial. Patel KV, Mauricio R, Grodin JL, Ayers C, Fonarow GC, Berry JD, Pandey A, ESC Heart Fail 2019 Apr Generalizability and Implications of the H2FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction. Segar MW, Patel KV, Berry JD, Grodin JL, Pandey A, Circulation 2019 Apr 139 15 1851-1853 Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights from ASCEND-HF. Grodin JL, Liebo MJ, Butler J, Metra M, Felker GM, Hernandez AF, Voors AA, McMurray JJ, Armstrong PW, O'Connor C, Starling RC, Troughton RW, Wilson Tang WH, J. Card. Fail. 2019 Apr Temporal association between hospitalization event and subsequent risk of mortality among patients with stable chronic heart failure with preserved ejection fraction: insights from the TOPCAT trial. Pandey A, Patel KV, Ayers C, Tang WHW, Fang JC, Drazner MH, Berry J, Grodin JL, Eur. J. Heart Fail. 2019 Apr Delayed febrile response with bloodstream infections in patients with continuous-flow left ventricular assist devices. Wrobel CA, Drazner MH, Ayers CR, Pham DD, La Hoz RM, Grodin JL, Garg S, Mammen PPA, Morlend RM, Araj F, Amin AA, Cornwell WK, Thibodeau JT J. Investig. Med. 2019 Mar 67 3 653-658 High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. Aimo A, Januzzi JL, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Rocca HB, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Wilson Tang WH, Grodin JL, Passino C, Emdin M Int. J. Cardiol. 2019 Feb 277 166-172 Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT. Grodin JL, Philips S, Mullens W, Nijst P, Martens P, Fang JC, Drazner MH, Tang WHW, Pandey A Eur. J. Heart Fail. 2019 Feb Results 1-10 of 57 1 2 3 4 5 Next Last Books Featured Books Preventive Strategies for Other Cardiovascular Diseases: Prevension of Heart Failure. In Cardiology: An Illustrated Textbook Chatterjee (2016). Jaypee Brothers Medical Publishers Hypertension and Cardiomyopathies. In Case Files in Cardiology Faulx and Toy. (2015). McGraw-Hill Education Honors & Awards Nominee for APP Champion of the Year (2021) LEAD ProgramOffice of Faculty Development, UT Southwestern Medical Center (2020-2021) Nominee for APP Champion of the Year (2020) Texas Health Resources Clinical Scholar Award (2018) Emerging Faculty CourseAmerican College of Cardiology (2017) The Lower Clinical Award, Cleveland Clinic (2016) Young Investigator GrantCardiovascular Clinical Trialists (CVCT) Forum (2016) Best Fellow In-Training Poster at the American College of Cardiology Scientific Sessions (2014) Gus P. Karos Foundation Scholarship, Cleveland Clinic (2013) Best Published Paper, UT Southwestern Internal Medicine Residency (2012) Professional Associations/Affiliations American College of Cardiology American Heart Association Heart Failure Society of America International Society of Amyloidosis
